Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies [Phase 1]
A Phase 1 clinical trial update reports the completion of a study evaluating intravenously administered SNS-032 in patients with advanced B-…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs [Phase 2]
A Phase 2 safety and tolerability trial evaluating CDX-301 with or without plerixafor for stem cell mobilization in matched related donor/re…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia [Phase 2]
Phase 2 trial evaluating tipifarnib in patients with anemia or neutropenia and large granular lymphocytic leukemia, including chronic lympho…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating fludarabine and rituximab with or without lenalidomide or cyclophosphamide in symptomatic chronic lymphocytic leuke…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia [Phase 3]
A Phase 3 trial evaluating idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukemia was terminated with…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
An observational trial of Rituximab (MabThera/Rituxan) in relapsing or refractory chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant [Phase 2]
Phase 2 study evaluating lenalidomide with or without rituximab in patients with relapsed or progressive chronic lymphocytic leukemia, small…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL [Phase 2]
A Phase 2 trial evaluating dasatinib in combination with fludarabine and rituximab in relapsed or refractory chronic lymphocytic leukemia an…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase II study of vismodegib in refractory or relapsed B-cell lymphoma or chronic lymphocytic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Tandem Auto-Allo Transplant for Lymphoma [Phase 2]
Phase 2 clinical trial update on tandem auto-allo transplantation for various lymphomas, with completed status and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia [EARLY_Phase 1]
An early-phase 1 trial evaluated pretreatment with valproate before CD20-targeted immunotherapy in chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy [Phase 1]
Phase 1 trial evaluating CART19 therapy for B-cell hematologic malignancies including various lymphomas and leukemias that are refractory or…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 study evaluating pentostatin, cyclophosphamide, and rituximab in patients with previously untreated chronic lymphocytic leukemia. Th…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma [Phase 3]
Phase 3 trial comparing ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma com…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714) [Phase 3]
A Phase 3 study comparing dinaciclib to ofatumumab in patients with refractory chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant [Phase 1, Phase 2]
This update covers a phase 1/2 clinical trial evaluating CD19 CAR T cells for B-cell malignancies in patients after allogeneic transplantati…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia [NA]
Duke University's clinical trial evaluating a quality-improvement approach to the management of chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]
First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lympho…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating pentostatin and rituximab, with or without cyclophosphamide, in previously untreated chronic lymphocytic leukemia (…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of fludarabine, rituximab, and alemtuzumab in patients with chronic lymphocytic leukemia or small…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating the combination of etanercept and rituximab in patients with chron…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated [Phase 1]
A Phase 1 dose-finding study evaluated CpG in previously treated patients with Chronic Lymphocytic Leukemia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating denileukin diftitox in fludarabine-refractory B-cell chronic lymphocytic leukemia has completed.